semaglutide dpp4 Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA dpp-4_inhibitors [TUSOM | Pharmwiki]

Unlike some compounded regimens that allow for flexible or micro-dosed schedules, FDA-approved GLP-1s have specific dosing timelines (usually weekly)

Deficiency rates in GLP-1 users, per Butsch et al., 2025: vitamin D 7.5% at 6 months rising to 13.6% at 12 months

TE also increased blood pressure and heart rate, but the effects were similar to or less than those of another medication called sibutramine

doi:10.1002/jcph.2483 45

After graduation he worked for 8 years in private practice, and made the switch back to academics and came back to Ohio State to continue his career

Journal of Pharmacology and Experimental Therapeutics (2024) 3